av/natco-pharma--big.svg

NSE:NATCOPHARM

NATCO Pharma

  • Stock

INR

Last Close

1,357.60

25/11 09:40

Market Cap

212.46B

Beta: 0.42

Volume Today

445.59K

Avg: 330.36K

PE Ratio

13.65

PFCF: -

Dividend Yield

1.11%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
1.64B
-
2.01B
22.61%
2.89B
43.92%
3.53B
22.33%
3.94B
11.49%
4.84B
22.88%
5.43B
12.36%
6.78B
24.77%
7.80B
15.04%
7.52B
3.54%
7.67B
1.97%
average payables
1.06B
-
1.18B
10.87%
639.28M
45.61%
22.78M
96.44%
34M
49.27%
1.11B
3,161.76%
2.36B
112.98%
2.01B
14.99%
1.54B
23.31%
2.13B
38.18%
2.50B
17.32%
average receivables
1.46B
-
1.81B
24.10%
2.92B
61.96%
4.49B
53.38%
6.22B
38.65%
7.01B
12.73%
3.43B
51.11%
2.35B
31.36%
5.71B
142.58%
7.69B
34.66%
10.22B
33.03%
book value per share
45.44
-
51.09
12.42%
76.17
49.09%
94.66
24.28%
173.26
83.03%
189.41
9.32%
207.41
9.50%
226.26
9.09%
233.75
3.31%
266.96
14.21%
326.07
22.14%
capex per share
-6.91
-
-7.20
4.18%
-9.23
28.26%
-16.04
73.76%
-23.93
49.16%
-25.06
4.74%
-19.71
21.36%
-13.98
29.09%
-13.31
4.80%
-11.26
15.36%
18.91
267.89%
capex to depreciation
-3.63
-
-2.52
30.43%
-3.09
22.46%
-5.14
66.35%
-6.41
24.75%
-5.70
11.07%
-3.59
36.96%
-2.18
39.39%
-1.70
21.85%
-1.26
26.25%
1.82
244.75%
capex to operating cash flow
-0.77
-
-1.29
67.89%
-1.54
19.49%
-0.81
47.42%
-0.92
13.23%
-0.69
24.57%
-0.86
24.48%
-0.85
0.84%
-5.22
512.55%
-0.24
95.36%
0.28
215.69%
capex to revenue
-0.15
-
-0.15
3.58%
-0.14
3.93%
-0.14
2.06%
-0.20
43.59%
-0.22
13.82%
-0.19
15.17%
-0.15
20.71%
-0.13
15.41%
-0.08
40.39%
0.08
211.66%
cash per share
0.66
-
0.76
15.01%
3.82
403.03%
7.87
106.41%
47.73
506.09%
57.41
20.29%
49.61
13.60%
44.48
10.34%
41.66
6.33%
63.65
52.79%
99.06
55.62%
days of inventory on hand
239.72
-
283.50
18.26%
331.72
17.01%
183.50
44.68%
314.44
71.35%
418.02
32.94%
399.35
4.47%
479.26
20.01%
408.11
14.85%
432.26
5.92%
335.04
22.49%
days payables outstanding
145.30
-
161.47
11.13%
2.37
98.53%
1.05
55.66%
3.44
227.29%
171.48
4,880.84%
182.79
6.60%
87.78
51.98%
86.66
1.28%
153.49
77.13%
99.66
35.07%
days sales outstanding
72.97
-
95.89
31.41%
120.02
25.16%
94.35
21.39%
121.28
28.54%
121.37
0.08%
101.62
-
128.57
26.52%
116.80
9.15%
108.43
7.17%
debt to assets
0.20
-
0.23
12.07%
0.06
72.74%
0.10
54.99%
0.05
51.24%
0.09
92.56%
0.07
20.02%
0.06
17.48%
0.08
42.72%
0.03
65.15%
0.05
85.80%
debt to equity
0.33
-
0.37
11.30%
0.09
76.59%
0.13
55.04%
0.06
58.04%
0.11
96.39%
0.09
21.16%
0.07
21.09%
0.10
47.10%
0.03
66.24%
0.06
88.87%
dividend yield
0.01
-
0.00
62.37%
0.00
29.86%
0.01
156.97%
0.01
39.26%
0.01
19.75%
0.02
56.92%
0.01
54.65%
0.01
21.31%
0.01
63.80%
0.01
0.10%
earnings yield
0.04
-
0.02
52.14%
0.02
14.46%
0.03
48.91%
0.05
54.95%
0.06
21.60%
0.05
19.06%
0.03
41.48%
0.01
57.96%
0.07
464.26%
0.08
14.21%
enterprise value
27.82B
-
72.86B
161.86%
71.03B
2.51%
149.93B
111.09%
138.29B
7.76%
107.69B
22.13%
95.07B
11.72%
152.96B
60.89%
141.13B
7.73%
103.20B
26.88%
177.94B
72.43%
enterprise value over ebitda
14.36
-
32.44
125.84%
24.62
24.12%
20.79
15.53%
14.26
31.40%
11.83
17.06%
14.08
19.00%
22.33
58.63%
42.26
89.23%
9.92
76.52%
9.47
4.57%
ev to operating cash flow
19.32
-
78.62
307.02%
69.38
11.76%
43.36
37.50%
29.83
31.20%
16.10
46.02%
22.78
41.49%
51.19
124.70%
303.51
492.89%
12.15
96.00%
14.69
20.84%
ev to sales
3.81
-
8.90
133.75%
6.31
29.05%
7.35
16.40%
6.41
12.76%
5.22
18.54%
5.04
3.58%
9.05
79.69%
7.41
18.13%
3.81
48.55%
4.45
16.64%
free cash flow per share
2.11
-
-1.60
176.04%
-3.23
101.28%
3.81
217.95%
2.22
41.76%
11.24
407.26%
3.23
71.30%
2.43
24.79%
-10.76
543.30%
35.25
427.69%
47.51
34.80%
free cash flow yield
0.01
-
-0.00
128.79%
-0.01
105.71%
0.00
157.32%
0.00
35.88%
0.02
592.32%
0.01
67.92%
0.00
53.95%
-0.01
583.98%
0.06
539.83%
0.05
22.01%
graham net net
-15.79
-
-15.04
4.76%
0.03
100.20%
2.46
8,046.03%
54.36
2,106.32%
55.60
2.29%
20.80
62.59%
49.06
135.90%
43.78
10.76%
310.20
608.47%
112.11
63.86%
graham number
81.10
-
96.67
19.20%
124.91
29.22%
243.75
95.14%
391.24
60.51%
386.12
1.31%
343.80
10.96%
351.03
2.10%
221.40
36.93%
485.12
119.12%
753.26
55.27%
income quality
1.12
-
0.69
38.18%
0.50
28.23%
0.55
11.77%
0.52
5.65%
0.81
55.20%
0.73
9.52%
0.52
29.74%
0.23
55.39%
0.99
328.38%
0.87
11.41%
intangibles to total assets
0.03
-
0.03
24.02%
0.00
85.27%
0.00
48.83%
0.00
26.92%
0.00
36.35%
0.00
5.13%
0.00
2.27%
0.03
1,226.05%
0.03
27.61%
0.03
15.77%
interest coverage
4.39
-
5.64
28.45%
11.14
97.56%
40.97
267.87%
66.33
61.89%
44.32
33.18%
27.75
37.39%
56.93
105.15%
16.66
70.74%
60.44
262.81%
135.22
123.72%
interest debt per share
17.26
-
20.74
20.15%
7.85
62.18%
13.64
73.82%
10.51
22.92%
21.85
107.85%
19.08
12.69%
16.07
15.78%
24.41
51.90%
9.93
59.34%
22.13
123.00%
inventory turnover
1.52
-
1.29
15.44%
1.10
14.54%
1.99
80.77%
1.16
41.64%
0.87
24.78%
0.91
4.68%
0.76
16.67%
0.89
17.43%
0.84
5.59%
1.09
29.02%
invested capital
0.33
-
0.37
11.30%
0.09
76.59%
0.13
55.04%
0.06
58.04%
0.11
96.39%
0.09
21.16%
0.07
21.09%
0.10
47.10%
0.03
66.24%
56.79B
166,030,806,478,604.25%
market cap
25.51B
-
69.85B
173.80%
70.34B
0.71%
147.95B
110.33%
136.78B
7.55%
104.11B
23.88%
91.98B
11.66%
150.38B
63.50%
137.92B
8.28%
102.85B
25.43%
174.79B
69.94%
net current asset value
-948.17M
-
-500.03M
47.26%
3.12B
723.46%
4.23B
35.72%
14.92B
252.54%
15.35B
2.92%
15.22B
0.82%
16.69B
9.61%
16.52B
1.02%
64.80B
292.34%
29.70B
54.16%
net debt to ebitda
1.19
-
1.34
12.19%
0.24
82.29%
0.27
15.80%
0.16
43.12%
0.39
151.67%
0.46
16.57%
0.38
17.80%
0.96
154.99%
0.03
96.52%
0.17
402.08%
net income per share
6.43
-
8.13
26.39%
9.10
11.99%
27.89
206.40%
39.26
40.76%
34.98
10.90%
25.33
27.60%
24.20
4.44%
9.32
61.49%
39.18
320.39%
77.34
97.40%
operating cash flow per share
9.02
-
5.60
37.94%
6.01
7.34%
19.85
230.44%
26.15
31.73%
36.31
38.87%
22.94
36.83%
16.40
28.48%
2.55
84.46%
46.51
1,724.38%
67.50
45.13%
payables turnover
2.51
-
2.26
10.01%
153.84
6,705.59%
347
125.56%
106.02
69.45%
2.13
97.99%
2.00
6.19%
4.16
108.23%
4.21
1.30%
2.38
43.54%
3.66
54.02%
receivables turnover
5.00
-
3.81
23.90%
3.04
20.10%
3.87
27.21%
3.01
22.20%
3.01
0.08%
3.59
-
2.84
20.96%
3.12
10.07%
3.37
7.72%
research and ddevelopement to revenue
0.02
-
0.02
21.21%
0.01
13.01%
0.02
68.32%
0.02
5.00%
0.04
63.92%
0.03
4.51%
0.09
159.89%
0.09
6.57%
0.03
64.12%
0.03
9.18%
return on tangible assets
0.09
-
0.10
13.96%
0.09
15.01%
0.21
145.87%
0.19
10.57%
0.15
20.18%
0.10
32.94%
0.09
8.39%
0.03
62.94%
0.13
282.81%
0.21
58.13%
revenue per share
45.75
-
49.43
8.05%
65.99
33.50%
117.08
77.42%
121.63
3.88%
111.93
7.98%
103.76
7.30%
92.79
10.57%
104.43
12.54%
148.28
41.98%
222.95
50.35%
roe
0.14
-
0.16
12.42%
0.12
24.88%
0.29
146.55%
0.23
23.10%
0.18
18.50%
0.12
33.88%
0.11
12.40%
0.04
62.73%
0.15
268.08%
0.24
61.61%
roic
0.11
-
0.13
22.41%
0.12
5.49%
0.27
118.22%
0.21
22.31%
0.14
31.73%
0.10
33.21%
0.09
9.99%
0.04
54.73%
0.14
267.26%
0.35
139.61%
sales general and administrative to revenue
0.04
-
0.03
19.10%
0.02
23.98%
0.02
16.92%
0.02
5.17%
0.02
41.12%
0.03
24.73%
0.03
7.50%
0.04
28.47%
0.04
8.04%
0.03
27.04%
shareholders equity per share
45.44
-
51.09
12.42%
76.17
49.09%
94.66
24.28%
173.26
83.03%
189.41
9.32%
207.41
9.50%
226.26
9.09%
233.75
3.31%
266.96
14.21%
326.07
22.14%
stock based compensation to revenue
0.01
-
0.01
29.98%
0.01
38.42%
0.01
47.03%
0.01
37.84%
0.01
2.28%
0.00
84.51%
tangible asset value
7.01B
-
8.05B
14.90%
12.94B
60.76%
16.48B
27.29%
30.64B
85.98%
34.82B
13.64%
37.76B
8.43%
41.14B
8.95%
41.31B
0.41%
89.50B
116.66%
56.60B
36.76%
tangible book value per share
43.87
-
48.62
10.82%
75.94
56.19%
94.57
24.53%
172.81
82.74%
189.04
9.39%
207.54
9.78%
225.85
8.82%
226.46
0.27%
490.21
116.47%
315.31
35.68%
working capital
558.54M
-
692.26M
23.94%
3.39B
390.28%
4.61B
35.77%
15.39B
233.92%
16.18B
5.19%
16.40B
1.35%
18.12B
10.45%
17.87B
1.37%
23.17B
29.68%
30.51B
31.65%

All numbers in INR (except ratios and percentages)